Article Details

Arbutus Biopharma Provides Update on the Phase 2A Combination Trial with AB-729 and a ...

Retrieved on: 2022-07-23 11:05:55

Tags for this article:

Click the tags to see associated articles and topics

Arbutus Biopharma Provides Update on the Phase 2A Combination Trial with AB-729 and a .... View article details on hiswai:

Excerpt

WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) announced that while its partner, Assembly Biosciences, recently decided to ...

Article found on: www.mychesco.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up